tiprankstipranks
Advertisement
Advertisement

VSTM Stock Latest News

Citizens healthcare analysts hold an analyst/industry conference call
The FlyCitizens healthcare analysts hold an analyst/industry conference call
4d ago
CTMX
EXEL
Verastem price target lowered to $14 from $15 at RBC Capital
PremiumThe Fly
Verastem price target lowered to $14 from $15 at RBC Capital
4d ago
VSTM
Verastem’s RAMP 204 Trial Completion Signals New Momentum in KRAS G12C Lung Cancer
PremiumCompany Announcements
Verastem’s RAMP 204 Trial Completion Signals New Momentum in KRAS G12C Lung Cancer
9d ago
VSTM
Cardiff, Verastem, Fluence, Quantum-Si, Opera Insider Shock
PremiumWeekend Updates
Cardiff, Verastem, Fluence, Quantum-Si, Opera Insider Shock
14d ago
QSI
CRDF
Verastem Advances VS-7375 with Promising Early Trial Data
PremiumCompany Announcements
Verastem Advances VS-7375 with Promising Early Trial Data
18d ago
8K
VSTM
Verastem reports ‘positive’ preliminary data from ongoing TARGET-D trial
PremiumThe FlyVerastem reports ‘positive’ preliminary data from ongoing TARGET-D trial
18d ago
VSTM
Verastem price target lowered to $8 from $15 at Jefferies
Premium
The Fly
Verastem price target lowered to $8 from $15 at Jefferies
18d ago
VSTM
Verastem’s KRAS G12D Pancreatic Cancer Trial Advances: What Investors Should Watch
Premium
Company Announcements
Verastem’s KRAS G12D Pancreatic Cancer Trial Advances: What Investors Should Watch
18d ago
VSTM
Verastem Advances VS-7375 Into Phase 2 Pancreatic Trial
PremiumCompany Announcements
Verastem Advances VS-7375 Into Phase 2 Pancreatic Trial
24d ago
8K
VSTM
Verastem announces safety, efficacy results from RAMP 205 Phase 1b/2a study
PremiumThe Fly
Verastem announces safety, efficacy results from RAMP 205 Phase 1b/2a study
24d ago
VSTM
Verastem doses first Patient in TARGET-D 201 Phase 2 trial of VS-7375
PremiumThe Fly
Verastem doses first Patient in TARGET-D 201 Phase 2 trial of VS-7375
25d ago
VSTM
3 Best Stocks to Buy Today, According to Top Analysts, 6/9/2026
PremiumMarket News
3 Best Stocks to Buy Today, According to Top Analysts, 6/9/2026
1M ago
EVLV
SPTX
Verastem up 11% at $4.00 after announcing FDA Fast Track designation for VS-7375
PremiumThe FlyVerastem up 11% at $4.00 after announcing FDA Fast Track designation for VS-7375
1M ago
VSTM
Verastem announces FDA Fast Track designation for VS-7375
Premium
The Fly
Verastem announces FDA Fast Track designation for VS-7375
1M ago
VSTM
Verastem Shareholders Back Board, Executive Pay and Plans
Premium
Company Announcements
Verastem Shareholders Back Board, Executive Pay and Plans
2M ago
8K
VSTM
Verastem appoints Michael Bailey to board of directors
PremiumThe Fly
Verastem appoints Michael Bailey to board of directors
2M ago
VSTM
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts
PremiumMarket News
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts
2M ago
WVE
REAX
Verastem price target lowered to $14 from $16 at Mizuho
PremiumThe Fly
Verastem price target lowered to $14 from $16 at Mizuho
2M ago
VSTM
Verastem Inc Earnings Call Highlights Growth And Risk
PremiumCompany Announcements
Verastem Inc Earnings Call Highlights Growth And Risk
2M ago
VSTM
Verastem price target lowered to $18 from $19 at BTIG
PremiumThe FlyVerastem price target lowered to $18 from $19 at BTIG
2M ago
VSTM
Verastem price target raised to $18 from $16 at Alliance Global
Premium
The Fly
Verastem price target raised to $18 from $16 at Alliance Global
2M ago
VSTM
Verastem reports Q1 adjusted EPS (43c), consensus (47c)
Premium
The Fly
Verastem reports Q1 adjusted EPS (43c), consensus (47c)
2M ago
VSTM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >